GILEAD SCIENCES INC
For the period ended Dec 31, 2024. Filed Feb 28, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 28, 2025
GILD$169.32+1.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
| December 31, | ||
|---|---|---|
| (in millions, except per share amounts) | 2024 | 2023 |
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $9,991 | $6,085 |
| Short-term marketable debt securities | — | 1,179 |
| Accounts receivable, net | 4,420 | 4,660 |
| Inventories | 1,710 | 1,787 |
| Prepaid and other current assets | 3,052 | 2,374 |
| Total current assets | 19,173 | 16,085 |
| Property, plant and equipment, net | 5,414 | 5,317 |
| Long-term marketable debt securities | — | 1,163 |
| Intangible assets, net | 19,948 | 26,454 |
| Goodwill | 8,314 | 8,314 |
| Other long-term assets | 6,146 | 4,792 |
| Total assets | $58,995 | $62,125 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities: | ||
| Accounts payable | $833 | $550 |
| Accrued rebates | 3,892 | 3,802 |
| Current portion of long-term debt and other obligations, net | 1,815 | 1,798 |
| Other current liabilities | 5,464 | 5,130 |
| Total current liabilities | 12,004 | 11,280 |
| Long-term debt, net | 24,896 | 23,189 |
| Long-term income taxes payable | 830 | 2,039 |
| Deferred tax liability | 724 | 1,588 |
| Other long-term obligations | 1,295 | 1,280 |
| Commitments and contingencies (Note 13) | ||
| Stockholders’ equity: | ||
| Preferred stock, par value $0.001 per share; 5 shares authorized; none outstanding | — | — |
| Common stock, par value $0.001 per share; 5,600 authorized; 1,246 shares issued and outstanding | 1 | 1 |
| Additional paid-in capital | 7,700 | 6,500 |
| Accumulated other comprehensive income | 132 | 28 |
| Retained earnings | 11,497 | 16,304 |
| Total Gilead stockholders’ equity | 19,330 | 22,833 |
| Noncontrolling interest | (84) | (84) |
| Total stockholders’ equity | 19,246 | 22,749 |
| Total liabilities and stockholders’ equity | $58,995 | $62,125 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.